-James G Krueger Researcher Activity Profile

Research Author Detailed Information 

James G Krueger Publication Rate By Year

James G Krueger has published 1 paper(s) in 2006, 9 paper(s) in 2007, 4 paper(s) in 2008, for a total of 14 research publications in total.

James G Jg Krueger Author Information

LAST NAME: krueger

FIRST NAME: James G

INITIALS: jg

AFFILIATION:

Papers

James G Krueger's Publication Record

1. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. Year Published: 2007
Laboratory for Investigative Dermatology, Rockefeller University, New York, NY 10021, USA.
2. Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers. Year Published: 2006
Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey.
3. Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series. Year Published: 2007
Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, USA. jgk@rockefeller.edu.
4. Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patients. Year Published: 2007
Laboratory for Investigative Dermatology, Rockefeller University, New York, NY 10021, USA.
5. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. Year Published: 2007
Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York 10021, USA.
6. Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research. Year Published: 2007
Laboratory for Investigative Dermatology, The Rockefeller University, Box 178, 1230 York Avenue, New York, NY 10021, U.S.A.
7. Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research. Year Published: 2007
Laboratory for Investigative Dermatology, The Rockefeller University, Box 178, 1230 York Avenue, New York, NY 10021, USA. Guttman-Yassky
8. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. Year Published: 2007
Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY 10065.
9. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. Year Published: 2007
Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY 10065, USA. lzaba@rockefeller.edu
10. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. Year Published: 2007
Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY 10065, USA. lzaba@rockefeller.edu
11. Identification of Cellular Pathways of "Type 1," Th17 T Cells, and TNF- and Inducible Nitric Oxide Synthase-Producing Dendritic Cells in Autoimmune Inflammation through Pharmacogenomic Study of Cyclosporine A in Psoriasis. Year Published: 2008
Laboratory for Investigative Dermatology, Rockefeller University, New York, NY, 10021.
12. Cellular genomic maps help dissect pathology in human skin disease. Year Published: 2008
Laboratory of Investigative Dermatology, The Rockefeller University, New York, New York 10021-6399, USA.
13. Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome. Year Published: 2008
Department of Investigative Dermatology, Laboratory of Investigative Dermatology, The Rockefeller University, New York, New York 10021, USA.
14. Identification of cellular pathways of "type 1," Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. Year Published: 2008
Laboratory for Investigative Dermatology, Rockefeller University, New York, NY, 10021, USA.